Previous 10 | Next 10 |
2024-02-11 08:00:00 ET As the quarterly earnings season continues, the upcoming week promises a flurry of reports from industry titans spanning a diverse array of sectors. From energy to semiconductors, cybersecurity to consumer packaged goods, the market will be abuzz with updates fr...
The first and only monthly Water Gradient multifocal contact lens that feels like nothing – even at day 30 1 Provides excellent visual acuity at all distances, near through far, with Alcon’s proven Precision Profile design that fits in two easy steps, delivering 96% fit ...
2024-02-01 03:21:00 ET Summary Laughing Water Capital is a concentrated, long biased investment partnership open to accredited investors. Our interests are fully aligned with our partners as nearly all of our personal wealth is invested in our strategy. For Q4 2023, Class A intere...
2024-01-23 12:45:01 ET Bernstein analyst issues OUTPERFORM recommendation for ALC on January 23, 2024 12:47PM ET. ALC was trading at $76.9168 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 8 - Buy, 1 - H...
2024-01-16 16:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-15 15:49:19 ET More on Align Technology, DexCom, etc. Intuitive Surgical: Strong Pre-Announced Q4 - Time To Harvest The Gain, Initiate With 'Sell' Intuitive Surgical, Inc. (ISRG) JPMorgan Healthcare Conference Call Transcript Intuitive Surgical: Sustained Gro...
2024-01-10 05:30:47 ET Related stories: WD-40 Company (WDFC) Q1 2024 Earnings Call Transcript Coinbase: Why This Exchange Is A Better Investment Than Buying Cryptocurrencies Marathon Digital Holdings: Overhyped And Overbought Alcon reports positive Phase 3 re...
2024-01-09 17:14:06 ET More on Alcon Alcon Inc. (ALC) Q3 2023 Earnings Call Transcript Alcon Inc. 2023 Q3 - Results - Earnings Call Presentation Baird names top medtech picks for 2024; bullish on Alcon, Axonics Alcon Q3 2023 Earnings Preview Seeking A...
AR-15512, a topical transient receptor potential melastatin 8 (TRPM8) agonist, is a first-in-class product candidate for the treatment of the signs and symptoms of dry eye disease In both pivotal efficacy and safety studies (COMET-2 and COMET-3), the primary endpoint was achieved (p <0...
2024-01-06 00:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
Combined vitreoretinal-cataract system (VCS) and standalone cataract system (CS) are cleared for use in the U.S. New, proprietary technologies designed to deliver transformative surgical innovation Alcon to immediately begin collecting real-world user experience in the U.S. prior ...
2024-06-09 17:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Shares of Alcon Inc. (NYSE: ALC) traded at a new 52-week high today and are currently trading at $91.69. So far today, approximately 136.09k shares have been exchanged, as compared to an average 30-day volume of 907.93k shares. Alcon Inc., an eye care company, researches, develops, manufactur...